Icon - Menu open Search

The Canadian Cancer Research Alliance

Register Now
We’re an alliance of organizations that work strategically to co-ordinate and collaborate on most of the cancer research conducted in Canada. Together, we support cancer research that uncovers factors which may cause cancer, and discovers more—and better—treatments to improve patient and survivor outcomes. Since 2008, the Canadian Partnership Against Cancer, steward of the Canadian Strategy for Cancer Control (CSCC), provides secretariat and other supports to the CCRA to enable its members to regularly convene, network, and carry out its core activities.
Learn About Us
Our members maximize their collective impact to support research that benefits all people in Canada affected by cancer.
Learn Who We Are
Investment Report
Our annual report focuses on investments in cancer research and our special topics reports focus on investments in key areas.
View More in Reports
Patient Involvement
CCRA members value the participation and engagement of patients in all stages and phases of cancer research.
Learn More

Canadian Cancer Research Conference

The Canadian Cancer Research Conference (CCRC) provides the opportunity to hear about the latest developments across the spectrum of cancer research and network with other disciplines.

Join us at the CCRC 2025, in person in Calgary, AB from November 2-4, 2025.

Conference Details
attendees at a canadian cancer research conference ccrc

News

Two Leading Cancer Researchers Appointed as Officers of the Order of Canada

The CCRA congratulates Drs. Anne-Marie Mes-Masson and John Bell, two distinguished cancer researchers and past CCRA awardees, for their appointments as Officers of the Order of Canada in late December 2025. Anne-Marie Mes-Masson, PhD, FCAHS, FRSC, Associate Scientific Director of basic and translational research at the Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), is recognized for her work in developing biobanks and significant scientific discoveries in o...

New CCRA Advisory Board Chair and Elected Representative

Effective January 1, 2026, CCRA welcomes new CCRA Advisory Board chair, Dr. James (Jim) Woodgett. Jim is the President and Scientific Director of the Terry Fox Research Institute (TFRI), a Senior Scientist at the Lunenfeld-Tanenbaum Research Institute at Sinai Health and Professor in the Department of Medical Biophysics at the University of Toronto. During his tenure as President and Scientific Director at TFRI, Jim has successfully secured additional Federal support for the Marathon of Hope ...

Outstanding Contributions to the Canadian Cancer Research Community

Today, the CCRA recognizes six leaders in Canadian cancer research, including two inaugural Indigenous awards recipients. The CCRA Awards, initiated in 2011, recognize and celebrate on a biennial basis the outstanding contributions of individuals who have had a remarkable impact on cancer research and the cancer research community. This year’s inaugural Award for Excellence in a First Nations, Inuit and Métis Community Project is Sitansisk Wolastoqey (St. Mary’s First Nation), represented ...

Investment in Cancer Research in 2022

Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research investment was fairly flat from 2019-2022, although the number of new and in-progress projects continued to decline. Research investment in breast, prostate and blood cancers declined from 2020 on and investment in operating grants fel...
View All News

Tools & Reports

annual snapshot
Annual Snapshot
Learn More
aya front page
Childhood and Adolescent Cancers: Research Investment
Learn More
cancer survivorship visualization
Investment in Cancer Survivorship Research
Learn More